natgillin/translations-raw huggingface dataset:
Abseamed is prescribed to stimulate your bone marrow to produce more red blood cells. 
Zdravilo Abseamed se predpisuje za spodbujanje kostnega mozga k tvorbi rdečih krvnih celic.
• Before use, leave the Abseamed syringe to stand until it reaches room temperature. 
• Pred uporabo počakajte, da zdravilo Abseamed doseže sobno temperaturo.
Instructions on how to inject yourself with Abseamed can be found at the end of this leaflet. 
Navodila za to, kako si sami injicirate zdravilo Abseamed, lahko najdete na koncu tega navodila za uporabo zdravila.
Abseamed is used to treat anaemia in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma (bone marrow cancer) who may have a need for a blood transfusion. 
Zdravilo Abseamed se uporablja za zdravljenje anemije pri odraslih, če prejemate kemoterapijo za solidne tumorje, maligni limfom ali multipli mielom (rak kostnega mozga), ki morda potrebujejo transfuzijo krvi.
In chronic renal failure patients the rate of increase in haemoglobin should be approximately 1 g/dL (0.62 mmol/L) per month and should not exceed 2 g/dL (1.25 mmol/L) per month to minimise risks of an increase in hypertension. 
Pri bolnikih s kroničnim ledvičnim odpovedovanjem mora biti stopnja zvišanja hemoglobina približno 1 g/dl (0,62 mmol/l) na mesec in ne sme presegati 2 g/dl (1,25 mmol/l) na mesec, da se zmanjša tveganje zvišanja pri hipertenziji.
What Abseamed looks like and contents of the pack 
Izgled zdravila Abseamed in vsebina pakiranja
Abseamed should be administered as a subcutaneous injection. 
Zdravilo Abseamed je treba dati v obliki subkutane injekcije.
How to use Abseamed 
Kako uporabljati zdravilo Abseamed
Caution should be exercised with escalation of Abseamed doses in patients with chronic renal failure. 
Previdnost je potrebna pri stopnjevanju odmerkov zdravila Abseamed pri bolnikih s kronično ledvično odpovedjo.
Some people, depending on why they need Abseamed treatment, may later learn how to inject themselves under the skin: see Instructions on how to inject Abseamed yourself at the end of the leaflet. 
Nekateri posamezniki se lahko kasneje naučijo, kako si lahko zdravilo sami injicirajo pod kožo, odvisno od tega, za kaj potrebujejo zdravilo Abseamed: glejte
The recommended starting dose is Abseamed 450 IU/kg (maximum total dose is 40,000 IU) administered subcutaneously once every week, with not less than 5 days between doses. 
Priporočeni začetni odmerek zdravila Abseamed je 450 i.e./kg (največji skupni odmerek je 40.000 i.e.), ki se daje subkutano enkrat na teden, pri čemer med odmerkoma ne sme miniti manj kot
• You may be given iron supplements before and during Abseamed treatment to make it more effective. 
• Med zdravljenjem z zdravilom Abseamed in po njem boste morda prejemali tudi nadomestno železo za povečanje učinkovitosti zdravila.
Abseamed contains sodium 
Zdravilo Abseamed vsebuje natrij
When treatment starts, Abseamed is usually injected by a medical professional or a nurse. 
Na začetku zdravljenja vam bo zdravilo Abseamed običajno injiciral zdravnišk ali medicinsko osebje.
Abseamed is a sterile but unpreserved product and is for single use only. 
Zdravilo Abseamed je sterilno, brez dodatka konzervansa, namenjeno zgolj enkratni uporabi.
Patients should be monitored closely to ensure that the lowest approved dose of Abseamed is used to provide adequate control of anaemia and of the symptoms of anaemia. 
Bolnike je treba skrbno spremljati, da se zagotovi uporaba najmanjšega odobrenega odmerka zdravila Abseamed za doseganje ustreznega nadzora anemije in njenih simptomov.
Stop using Abseamed if you develop these symptoms and contact your doctor or seek medical attention immediately. 
Če se pri vas pojavijo ti simptomi, prenehajte uporabljati zdravilo Abseamed in se takoj posvetujte z zdravnikom ali poiščite zdravniško pomoč.
Before use, leave the Abseamed syringe to stand until it reaches room temperature. 
Pred uporabo počakajte, da zdravilo Abseamed doseže sobno temperaturo.
Take special care with Abseamed: 
Pri uporabi zdravila Abseamed bodite posebej previdni:
Instructions on how to inject Abseamed yourself 
Navodila, kako si sami injicirate zdravilo Abseamed
In cases where there is a medical need to shorten the lead time before surgery to less than three weeks, Abseamed 300 IU/kg should be administered subcutaneously daily for 10 consecutive days prior to surgery, on the day of surgery and for four days immediately thereafter. 
Kadar moramo zaradi zdravstvenih razlogov skrajšati čas pred kirurškim posegom na manj kot tri tedne, je treba dajati 300 i.e./kg zdravila Abseamed subkutano na dan, in sicer 10 dni zapored pred kirurškim posegom, na dan kirurškega posega in še štiri dni takoj po njem.
Package leaflet: Information for the patient Abseamed 1,000 IU/0.5 mL solution for injection in a pre-filled syringe Abseamed 2,000 IU/1 mL solution for injection in a pre-filled syringe Abseamed 3,000 IU/0.3 mL solution for injection in a pre-filled syringe Abseamed 4,000 IU/0.4 mL solution for injection in a pre-filled syringe Abseamed 5,000 IU/0.5 mL solution for injection in a pre-filled syringe Abseamed 6,000 IU/0.6 mL solution for injection in a pre-filled syringe Abseamed 7,000 IU/0.7 mL solution for injection in a pre-filled syringe Abseamed 8,000 IU/0.8 mL solution for injection in a pre-filled syringe Abseamed 9,000 IU/0.9 mL solution for injection in a pre-filled syringe Abseamed 10,000 IU/1 mL solution for injection in a pre-filled syringe Abseamed 20,000 IU/0.5 mL solution for injection in a pre-filled syringe Abseamed 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Abseamed 40,000 IU/1 mL solution for injection in a pre-filled syringe Epoetin alfa Read all of this leaflet carefully before you start using this medicine because it contains important information for you. 
NAVODILO ZA UPORABO Abseamed 1.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 2.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 3.000 i.e./0,3 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 4.000 i.e./0,4 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 5.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 6.000 i.e./0,6 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 7.000 i.e./0,7 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 8.000 i.e./0,8 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 9.000 i.e./0,9 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 10.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 20.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 30.000 i.e./0,75 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 40.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi epoetin alfa Pred začetkom uporabe zdravila natančno preberite navodilo, ker vsebuje za vas pomembne podatke!
Side effects from an overdose of Abseamed are unlikely. 
Ni verjetno, da bi se pojavili neželeni učinki zaradi prevelikega odmerka zdravila
Abseamed 1,000 IU/0.5 mL solution for injection in a pre-filled syringe Abseamed 2,000 IU/1 mL solution for injection in a pre-filled syringe Abseamed 3,000 IU/0.3 mL solution for injection in a pre-filled syringe Abseamed 4,000 IU/0.4 mL solution for injection in a pre-filled syringe Abseamed 5,000 IU/0.5 mL solution for injection in a pre-filled syringe Abseamed 6,000 IU/0.6 mL solution for injection in a pre-filled syringe Abseamed 7,000 IU/0.7 mL solution for injection in a pre-filled syringe Abseamed 8,000 IU/0.8 mL solution for injection in a pre-filled syringe Abseamed 9,000 IU/0.9 mL solution for injection in a pre-filled syringe Abseamed 10,000 IU/1 mL solution for injection in a pre-filled syringe Abseamed 20,000 IU/0.5 mL solution for injection in a pre-filled syringe Abseamed 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Abseamed 40,000 IU/1 mL solution for injection in a pre-filled syringe 
Abseamed 1.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 2.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 3.000 i.e./0,3 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 4.000 i.e./0,4 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 5.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 6.000 i.e./0,6 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 7.000 i.e./0,7 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 8.000 i.e./0,8 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 9.000 i.e./0,9 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 10.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 20.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 30.000 i.e./0,75 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Abseamed 40.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
In patients with chronic renal failure where intravenous access is routinely available (haemodialysis patients) administration of Abseamed by the intravenous route is preferable. 
Pri bolnikih s kronično ledvično odpovedjo, pri katerih je intravenski dostop rutinsko na razpolago (bolniki na hemodializi), je zaželeno intravensko dajanje zdravila Abseamed.
Abseamed contains less than 1 mmol sodium (23 mg) per dose that is to say essentially “sodium free”. 
Zdravilo Abseamed vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar v bistvu pomeni „brez natrija“.
Only one dose of Abseamed from each syringe should be taken. 
Odmeri se lahko le en odmerek zdravila Abseamed iz vsake brizge.
Abseamed should be administered to patients with symptomatic anaemia (e.g. haemoglobin concentration ≤ 10 g/dL (6.2 mmol/L)). 
Zdravilo Abseamed se daje bolnikom s simptomatsko anemijo (npr. koncentracijo hemoglobina ≤ 10 g/dl (6,2 mmol/l)).
• You may take Abseamed out of the refrigerator and keep it at room temperature (up to 25°C) for no longer than 3 days. 
• Zdravilo Abseamed lahko vzamete iz hladilnika in ga hranite pri sobni temperaturi (ne višji od
Tell your doctor or nurse immediately if you think too much Abseamed has been injected. 
Če ste uporabili večji odmerek zdravila Abseamed, kot bi smeli Takoj obvestite svojega zdravnika ali medicinsko sestro, če mislite, da ste injicirali prevelik odmerek zdravila Abseamed.
What is in this leaflet What Abseamed is and what it is used for What you need to know before you use Abseamed How to use Abseamed Possible side effects How to store Abseamed Contents of the pack and other information What Abseamed is and what it is used for Abseamed contains the active substance epoetin alfa, a protein that stimulates the bone marrow to produce more red blood cells which carry haemoglobin (a substance that transports oxygen). 
Kaj je zdravilo Abseamed in za kaj ga uporabljamo Zdravilo Abseamed vsebuje zdravilno učinkovino epoetin alfa, beljakovino, ki spodbuja kostni mozeg k tvorbi rdečih krvnih celic, ki prenašajo hemoglobin (snov, ki prenaša kisik).
Where intravenous access is not readily available Abseamed may be administered subcutaneously. 
Kjer intravenski dostop ni takoj na razpolago, se zdravilo Abseamed lahko daje subkutano.
What you need to know before you use Abseamed 
Kaj morate vedeti, preden boste uporabili zdravilo Abseamed Ne uporabljajte zdravila Abseamed:
If the haemoglobin concentration is increasing by more than 2 g/dL (1.25 mmol/L) per month, or if the haemoglobin concentration level exceeds 12 g/dL (7.5 mmol/L), reduce the Abseamed dose by about 25 to 50%. 
Če se koncentracija hemoglobina zveča za več kot 2 g/dl (1,25 mmol/l) na mesec, ali če raven koncentracije hemoglobina preseže 12 g/dl (7,5 mmol/l), zmanjšajte odmerek zdravila Abseamed za približno 25 do 50 %.
If the haemoglobin level reaches 15 g/dL (9.38 mmol/L), or higher, during the preoperative period, administration of Abseamed should be stopped and further dosages should not be administered. 
Če v obdobju pred kirurškim posegom raven hemoglobina doseže 15 g/dl (9,38 mmol/l) ali več, je treba zdravljenje z zdravilom Abseamed prekiniti.
Only take one dose of Abseamed from each syringe. 
Uporabite le en odmerek zdravila Abseamed iz vsake injekcijske brizge.
If the haemoglobin is rising by more than 2 g/dL (1.25 mmol/L) per month, or if the sustained haemoglobin exceeds 12 g/dL (7.5 mmol/L) reduce the Abseamed dose by 25%. 
Če se hemoglobin zviša za več kot 2 g/dl (1,25 mmol/l) na mesec, ali če stalna vrednost hemoglobina preseže 12 g/dl (7,5 mmol/l), zmanjšajte odmerek zdravila Abseamed za 25 %.
“Instructions on how to inject Abseamed yourself” can be found at the end of the package leaflet. 
„Navodila za samoinjiciranje zdravila Abseamed“ lahko najdemo na koncu navodila za uporabo.
Only take one dose of Abseamed from each syringe discarding unwanted solution before injection. 
Iz vsake brizge odvzemite samo en odmerek zdravila Abseamed in pred injiciranjem zavrzite preostalo raztopino.
Abseamed should be administered by the intravenous route. 
Zdravilo Abseamed je treba dati intravensko.
What Abseamed contains 
Kaj vsebuje navodilo
If the haemoglobin exceeds 13 g/dL (8.1 mmol/L), discontinue therapy until it falls below 12 g/dL (7.5 mmol/L) and then reinstitute Abseamed therapy at a dose 25% below the previous dose. 
Če hemoglobin preseže 13 g/dl (8,1 mmol/l), je treba zdravljenje prekiniti, dokler se ne zmanjša pod 12 g/dl (7,5 mmol/l), in nato zdravljenje nadaljevati z zdravilom Abseamed z odmerkom, ki je 25 % manjši od prejšnjega odmerka.
Epoetin alfa has been shown to stimulate erythropoiesis in anaemic patients with CRF, including dialysis and pre-dialysis patients. 
Kronična ledvična odpoved Pokazalo se je, da epoetin alfa spodbuja eritropoezo pri anemičnih bolnikih s kronično ledvično odpovedjo, vključno z bolniki, ki se zdravijo z dializo, in s tistimi, ki se z dializo še ne zdravijo.
INFORMATION IN BRAILLE Abseamed 8,000 IU/0.8 mL 
PODATKI V BRAILLOVI PISAVI Abseamed 8.000 i.e./0,8 ml
If you are a cancer patient be aware that products that stimulate red blood cell production (like Abseamed) may act as a growth factor and therefore in theory may affect the progression of your cancer. 
(kot je zdravilo Abseamed), delujejo kot rastni faktor in s tem teoretično vplivajo na napredovanje raka.
If the haemoglobin concentration level exceeds 13 g/dL (8.1 mmol/L), discontinue therapy until it falls below 12 g/dL (7.5 mmol/L) and then reinitiate Abseamed therapy at a dose 25% below the previous dose. 
Če raven koncentracije hemoglobina preseže 13 g/dl (8,1 mmol/l), je treba zdravljenje prekiniti, dokler se ne zmanjša pod 12 g/dl (7,5 mmol/l), in nato zdravljenje z zdravilom Abseamed začeti znova z odmerkom, ki je za približno 25 % manjši od predhodnega.
Abseamed should not be used: 
zdravila Abseamed ne smete uporabljati.
INFORMATION IN BRAILLE Abseamed 7,000 IU/0.7 mL 
PODATKI V BRAILLOVI PISAVI Abseamed 7.000 i.e./0,7 ml
- All contraindications associated with autologous blood predonation programmes should be respected in patients being supplemented with Abseamed. 
- Pri bolnikih, ki dobivajo zdravilo Abseamed, je treba upoštevati vse kontraindikacije, povezane s preddonorskimi programi avtolognega zbiranja krvi.
Abseamed 8,000 IU/0.8 mL solution for injection in a pre-filled syringe Each syringe contains 0.8 mL of solution for injection. 
Abseamed 8.000 i.e./0,8 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,8 ml raztopine za injiciranje.
Abseamed is provided with or without a needle safety guard and you will be shown how to use this by your doctor or nurse. 
vaš zdravnik ali medicinska sestra pa vam bosta pokazala, kako to uporabljati.
INFORMATION IN BRAILLE Abseamed 30,000 IU/0.75 mL 
PODATKI V BRAILLOVI PISAVI Abseamed 30.000 i.e./0,75 ml
INFORMATION IN BRAILLE Abseamed 9,000 IU/0.9 mL 
PODATKI V BRAILLOVI PISAVI Abseamed 9.000 i.e./0,9 ml
INFORMATION IN BRAILLE Abseamed 40,000 IU/1 mL 
PODATKI V BRAILLOVI PISAVI Abseamed 40.000 i.e./1 ml
INFORMATION IN BRAILLE Abseamed 6,000 IU/0.6 mL 
PODATKI V BRAILLOVI PISAVI Abseamed 6.000 i.e./0,6 ml
Abseamed 8,000 IU/0.8 mL solution for injection in a pre-filled syringe 
Abseamed 8.000 i.e./0,8 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
How to store Abseamed 
Shranjevanje zdravila Abseamed
INFORMATION IN BRAILLE Abseamed 4,000 IU/0.4 mL 
PODATKI V BRAILLOVI PISAVI Abseamed 4.000 i.e./0,4 ml
Abseamed 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Each syringe contains 0.75 mL of solution for injection. 
Abseamed 30.000 i.e./0,75 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,75 ml raztopine za injiciranje.
Abseamed 8,000 IU/0.8 mL solution for injection in a pre-filled syringe EU/1/07/412/013 
Abseamed 8.000 i.e./0,8 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/412/013
INFORMATION IN BRAILLE Abseamed 20,000 IU/0.5 mL 
PODATKI V BRAILLOVI PISAVI Abseamed 20.000 i.e./0,5 ml
Abseamed 7,000 IU/0.7 mL solution for injection in a pre-filled syringe Each syringe contains 0.7 mL of solution for injection. 
Abseamed 7.000 i.e./0,7 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,7 ml raztopine za injiciranje.
- in adults and children aged 1 to 18 years on haemodialysis and adult patients on peritoneal dialysis (see section 4.4). 
Zdravilo Abseamed je indicirano za zdravljenje simptomatske anemije, povezane s kronično ledvično odpovedjo: - pri odraslih in otrocih, starih 1 do 18 let, ki se zdravijo s hemodializo, in odraslih bolnikih, ki se zdravijo s peritonealno dializo (glejte poglavje 4.4).
Rare side effects These may affect up to 1 in 1,000 people. 
Pojavijo se lahko pri največ 1 od 1.000 bolnikov
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 9,000 IU/0.9 mL injection 
IME ZDRAVILA IN POT(I) UPORABE Abseamed 9.000 i.e./0,9 ml injekcija epoetin alfa i.v./s.c.
Abseamed 9,000 IU/0.9 mL solution for injection in a pre-filled syringe Each syringe contains 0.9 mL of solution for injection. 
Abseamed 9.000 i.e./0,9 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,9 ml raztopine za injiciranje.
Pre-filled syringe with needle safety guard 
Napolnjena injekcijska brizga z varnostno zaščito za iglo
INFORMATION IN BRAILLE Abseamed 5,000 IU/0.5 mL 
PODATKI V BRAILLOVI PISAVI Abseamed 5.000 i.e./0,5 ml
Abseamed 40,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 40,000 IU of epoetin alfa* corresponding to 336.0 micrograms per mL 
Abseamed 40.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 40.000 i.e. epoetina alfa*, kar ustreza 336,0 mikrogramov na ml. 1 ml napolnjena injekcijska brizga vsebuje 40.000 mednarodnih enot (i.e.), kar ustreza 336,0 mikrogramov epoetina alfa.
Abseamed 2,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 2,000 IU of epoetin alfa* corresponding to 16.8 micrograms per mL 
Abseamed 2.000 i.e./1 ml raztopina za injiciranje v napolnjeni injekcijski brizgi En ml raztopine vsebuje 2.000 i.e. epoetina alfa*, kar ustreza 16,8 mikrogramov na ml. 1 ml napolnjena injekcijska brizga vsebuje 2.000 mednarodnih enot (i.e.), kar ustreza 16,8 mikrogramov epoetina alfa.
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 7,000 IU/0.7 mL injection 
IME ZDRAVILA IN POT(I) UPORABE Abseamed 7.000 i.e./0,7 ml injekcija epoetin alfa i.v./s.c.
Abseamed 9,000 IU/0.9 mL solution for injection in a pre-filled syringe 
Abseamed 9.000 i.e./0,9 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
Abseamed 4,000 IU/0.4 mL solution for injection in a pre-filled syringe Each syringe contains 0.4 mL of solution for injection. 
Abseamed 4.000 i.e./0,4 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,4 ml raztopine za injiciranje.
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 8,000 IU/0.8 mL injection 
IME ZDRAVILA IN POT(I) UPORABE Abseamed 8.000 i.e./0,8 ml injekcija epoetin alfa i.v./s.c.
Abseamed 6,000 IU/0.6 mL solution for injection in a pre-filled syringe Each syringe contains 0.6 mL of solution for injection. 
Abseamed 6.000 i.e./0,6 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,6 ml raztopine za injiciranje.
INFORMATION IN BRAILLE Abseamed 2,000 IU/1 mL 
PODATKI V BRAILLOVI PISAVI Abseamed 2.000 i.e./1 ml
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 30,000 IU/0.75 mL injection 
IME ZDRAVILA IN POT(I) UPORABE Abseamed 30.000 i.e./0,75 ml injekcija epoetin alfa i.v./s.c.
Abseamed 30,000 IU/0.75 mL solution for injection in a pre-filled syringe EU/1/07/412/023 
Abseamed 30.000 i.e./0,75 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/412/023
IV/SC 
< 1 g/dl
Abseamed 5,000 IU/0.5 mL solution for injection in a pre-filled syringe Each syringe contains 0.5 mL of solution for injection. 
Abseamed 5.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,5 ml raztopine za injiciranje.
Abseamed 20,000 IU/0.5 mL solution for injection in a pre-filled syringe 
Abseamed 20.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
Abseamed 20,000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/412/021 
Abseamed 20.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/412/021
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 4,000 IU/0.4 mL injection 
IME ZDRAVILA IN POT(I) UPORABE Abseamed 4.000 i.e./0,4 ml injekcija epoetin alfa i.v./s.c.
Abseamed 3,000 IU/0.3 mL solution for injection in a pre-filled syringe Each syringe contains 0.3 mL of solution for injection. 
Abseamed 3.000 i.e./0,3 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,3 ml raztopine za injiciranje.
Abseamed 6,000 IU/0.6 mL solution for injection in a pre-filled syringe EU/1/07/412/011 
Abseamed 6.000 i.e./0,6 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/412/011
Abseamed 3,000 IU/0.3 mL solution for injection in a pre-filled syringe 
Abseamed 3.000 i.e./0,3 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
Abseamed 9,000 IU/0.9 mL solution for injection in a pre-filled syringe EU/1/07/412/019 
Abseamed 9.000 i.e./0,9 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/412/019
Abseamed 20,000 IU/0.5 mL solution for injection in a pre-filled syringe Each syringe contains 0.5 mL of solution for injection. 
Abseamed 20.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 0,5 ml raztopine za injiciranje.
Abseamed 7,000 IU/0.7 mL solution for injection in a pre-filled syringe EU/1/07/412/017 
Abseamed 7.000 i.e./0,7 ml raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/07/412/017
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 6,000 IU/0.6 mL injection 
IME ZDRAVILA IN POT(I) UPORABE Abseamed 6.000 i.e./0,6 ml injekcija epoetin alfa i.v./s.c.
Abseamed is indicated for the treatment of symptomatic anaemia (haemoglobin concentration of ≤ 10 g/dL) in adults with low- or intermediate-1-risk primary myelodysplastic syndromes (MDS) who have low serum erythropoietin (< 200 mU/mL). 
≤ 10 g/dl) pri odraslih s primarnimi mielodisplastičnimi sindromi (MDS) z nizkim ali srednjim-1
Abseamed 1,000 IU/0.5 mL solution for injection in a pre-filled syringe 
Abseamed 1.000 i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
INFORMATION IN BRAILLE Abseamed 10,000 IU/1 mL 
PODATKI V BRAILLOVI PISAVI Abseamed 10.000 i.e./1 ml